https://www.live-feeds.com/feed/hims-hers-surges-on-surprising-and-inevitable-deal-with-eli-lillyContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/hims-hers-surges-on-surprising-and-inevitable-deal-with-eli-lillyhttps://www.live-feeds.com/feed/hims-hers-surges-on-surprising-and-inevitable-deal-with-eli-lilly#u189962Tue, 10 Nov 2026 04:42:58 +0000Hims & Hers Health stock rose sharply after the company announced a partnership with Eli Lilly to sell the pharmaceutical giant's obesity medications directly through its telehealth platform. The deal gives Hims & Hers exclusive access to Lilly's branded weight-loss drugs, allowing direct-to-consumer sales and expanding the company's reach beyond its existing offerings. This move addresses a key need for the telehealth company to diversify its revenue streams amid competitive pressures in the digital health market.Why it mattersThe partnership represents a strategic expa